RNF2 promotes TGFβ signaling.

Slides:



Advertisements
Similar presentations
Figure S1 A B C D E F G Long Day Hypocotyl lenght (mm)
Advertisements

Volume 355, Issue 2, Pages (December 2014)
Effects of MAX reconstitution and of BRG1 depletion in lung cancer cells. Effects of MAX reconstitution and of BRG1 depletion in lung cancer cells. A,
Network protein vulnerability in EGFR TKI‐resistant cells and specific for EGFR‐mutated cells. Network protein vulnerability in EGFR TKI‐resistant cells.
Volume 15, Issue 6, Pages (June 2009)
Cell Physiol Biochem 2015;36: DOI: /
A Signal Transduction Pathway from TGF-β1 to SKP2 via Akt1 and c-Myc and its Correlation with Progression in Human Melanoma  Xuan Qu, Liangliang Shen,
miR-133a positively regulated p53/p21 pathway.
Volume 15, Issue 6, Pages (June 2012)
by Sang-Hyun Song, AeRi Kim, Tobias Ragoczy, M. A
DNMT3B Overexpression by Deregulation of FOXO3a-Mediated Transcription Repression and MDM2 Overexpression in Lung Cancer  Yi-Chieh Yang, MS, Yen-An Tang,
Volume 17, Issue 9, Pages (November 2016)
SDHB deficiency promotes TGFβ-mediated invasion and metastasis of colorectal cancer through transcriptional repression complex SNAIL1-SMAD3/4  Haiyu Wang,
Jongjoo Lee, Ivan Krivega, Ryan K. Dale, Ann Dean  Cell Reports 
MicroRNA-381 Represses ID1 and is Deregulated in Lung Adenocarcinoma
Volume 57, Issue 4, Pages (February 2015)
Volume 19, Issue 3, Pages (March 2017)
Identification of TLOC1 and SKIL as tumor driver genes in 3q26.
Tumor-Derived Fibronectin Is Involved in Melanoma Cell Invasion and Regulated by V600E B-Raf Signaling Pathway  Cédric Gaggioli, Guillaume Robert, Corine.
C-MYC induces the transcription of LIG3 and PARP1 in FLT3/ITD- and BCR-ABL1–positive cells. c-MYC induces the transcription of LIG3 and PARP1 in FLT3/ITD-
CHK1 downregulation upon ERG overexpression.
Wenqi Wang, Nan Li, Xu Li, My Kim Tran, Xin Han, Junjie Chen 
Volume 10, Issue 8, Pages (March 2015)
Microarray analysis of phospho-Twist1–responsive genes.
Volume 23, Issue 10, Pages (October 2016)
Volume 43, Issue 5, Pages (September 2011)
LATS2 promotes death of lumB cells.
NADPH Oxidase 1 Overexpression Enhances Invasion via Matrix Metalloproteinase-2 and Epithelial–Mesenchymal Transition in Melanoma Cells  Feng Liu, Angela.
Volume 23, Issue 3, Pages (March 2013)
Promotion Effects of miR-375 on the Osteogenic Differentiation of Human Adipose- Derived Mesenchymal Stem Cells  Si Chen, Yunfei Zheng, Shan Zhang, Lingfei.
Myeloma cell–derived Runx2 promotes myeloma progression in bone
Volume 3, Issue 6, Pages (December 2014)
RNF2 overexpression promotes invasion and metastasis in a catalytic activity–dependent manner. RNF2 overexpression promotes invasion and metastasis in.
Volume 25, Issue 10, Pages e4 (December 2018)
Volume 17, Issue 9, Pages (November 2016)
A genome-wide RNAi pooled screen identifies NF1 as a key determinant of RAF inhibitor sensitivity in melanoma cells. A genome-wide RNAi pooled screen identifies.
Xudong Wu, Jens Vilstrup Johansen, Kristian Helin  Molecular Cell 
Volume 19, Issue 6, Pages (September 2005)
Volume 20, Issue 13, Pages (September 2017)
MicroRNA-381 Represses ID1 and is Deregulated in Lung Adenocarcinoma
Volume 56, Issue 6, Pages (December 2014)
USP2a-dependent miRs deregulation modulates MYC expression.
MELK Promotes Melanoma Growth by Stimulating the NF-κB Pathway
The role of SRC-C3G-RAP1 signaling in transformation induced by CRKL
Volume 25, Issue 10, Pages (October 2017)
Volume 17, Issue 3, Pages (October 2016)
Cbx4 Sumoylates Prdm16 to Regulate Adipose Tissue Thermogenesis
Volume 20, Issue 13, Pages (September 2017)
Volume 63, Issue 1, Pages (July 2016)
Shipra Das, Olga Anczuków, Martin Akerman, Adrian R. Krainer 
EZH2 overexpression establishes a unique and conserved super-enhancer–associated transcriptional landscape. EZH2 overexpression establishes a unique and.
SATB2-AS1 repressed Snail transcription depending on SATB2-mediated recruitment of HDAC1. SATB2-AS1 repressed Snail transcription depending on SATB2-mediated.
Effect of G9a on the expression of GSH synthesis enzymes.
The expression of d-GM3 facilitates melanoma cell migration and invasion by activating p38 MAPK, not ERK. A, cell migration and invasion in d-GM3–positive.
Transcriptional and genomic targets of EN1 in TNBC cells.
EN1-associated chromatin complexes in breast cancer cells.
Ectopic expression of CA RSK1 mutant protects melanoma cells from PD98059-mediated apoptosis. Ectopic expression of CA RSK1 mutant protects melanoma cells.
PTEN expression regulates autophagy in tumor cells, reducing T cell–mediated killing. PTEN expression regulates autophagy in tumor cells, reducing T cell–mediated.
Pirh2 represses p73-dependent transactivation.
Effects of HDAC2 inactivation on the invasive potential of human gastric cancer cells. Effects of HDAC2 inactivation on the invasive potential of human.
Cell lines with aberrant expression of NRG1 are exquisitely sensitive to downregulation of ERBB3 signaling. Cell lines with aberrant expression of NRG1.
CREBBP loss-of-function results in gene expression repression signature. CREBBP loss-of-function results in gene expression repression signature. A–D,
RUNX3 depletion induces cellular senescence and inflammatory cytokine expression in cells undergoing TGFβ-mediated EMT. A, Cells were transfected with.
Effect of SPINDLIN1 protein on cancer cell proliferation and invasion.
HOXA11-AS acts as a ceRNA for miR-1297.
HOXA9 and STAT5 co-occupy similar genomic regions and increase JAK/STAT signaling. HOXA9 and STAT5 co-occupy similar genomic regions and increase JAK/STAT.
G34 H3K36me3 upregulates MYCN which is selectively targetable by kinases that destabilize the protein. G34 H3K36me3 upregulates MYCN which is selectively.
H3K36me3 is not essential for LEDGF and MLL target gene occupancy.
Coculture with U937 cells enhances DNMT1 expression in gastric cancer cells. Coculture with U937 cells enhances DNMT1 expression in gastric cancer cells.
Knockdown of ROR1 increases the invasive potential of melanoma cells in vitro and in vivo. Knockdown of ROR1 increases the invasive potential of melanoma.
Presentation transcript:

RNF2 promotes TGFβ signaling. RNF2 promotes TGFβ signaling. A, overlap of genes with corresponding promoters occupied by RNF2 (using ChIP-Seq data) and differentially expressed genes. As many as 363 genes show overlap, of which 169 (47%, green) are downregulated and 194 (53%, red) are upregulated. B, top 5 pathways from upstream regulating factor enrichment by Ingenuity Pathway Analysis (IPA). Note that TGFβ target genes were one of the most significantly deregulated and occupied genes. C, luciferase assay showing increased TGFβ-responsive promoter activity in HEK293 cells with overexpression of RNF2WT, but not with RNF2R70C and RNF2I53S. D, representative image from a Boyden chamber Matrigel invasion experiment in HMEL–BRAFV600E cells overexpressing GFP or RNF2WT and treated with DMSO or LY2157299 (TGFβRI inhibitor). Invaded cells stained with crystal violet are shown. E, occupancy of RNF2 on the LTBP2 promoter. Two ChIP-Seq tracks are shown: top: HMEL–BRAFV600E–RNF2WT tumor cells; bottom: HMEL–BRAFV600E–RNF2WT cells. F–G, (F) qPCR validation showing enrichment of V5-RNF2 (V5 antibody) and H2AK119ub on LTBP2 promoter and (G) mRNA expression of LTBP2 in HMEL–BRAFV600E cells overexpressing GFP, RNF2 wild-type or catalytic mutant derivatives (R70C and I53S). H and I, graph shows relative occupancy enrichment of RNF2 (endogenous), H2AK119ub, H3K9ac, H3K27ac, H4TetraAc, and IgG on LTBP2 promoter as obtained by ChIP-qPCR in shGFP or shRNF2-infected 501Mel (H) and WM983B (I) cells. J, relative mRNA expression of LTBP2 in shGFP or shRNF2-infected 501Mel or WM983B cells. K, Western blot showing protein levels of TGFβ target genes ID1, ID2, and ID3 in HMEL–BRAFV600E cells with knockdown of LTBP2 using two shRNAs. L and M, representative image of invaded cells from a triplicate Boyden chamber Matrigel invasion experiment in (L) HMEL–BRAFV600E or WM115 cells with knockdown of LTBP2 using two shRNAs and (M) HMEL–BRAFV600E cells overexpressing GFP or RNF2WT along with either RFP or LTBP2. N, graph showing quantitation of experiment shown in panel M. Across all panels, *, significant change t test P < 0.05 and **, P value < 0.01. Kunal Rai et al. Cancer Discov 2015;5:1314-1327 ©2015 by American Association for Cancer Research